![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Medical Care Technologies Inc (PK) | USOTC:MDCE | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0002 | -9.52% | 0.0019 | 0.0017 | 0.0021 | 0.0021 | 0.0015 | 0.002 | 5,319,499 | 21:02:25 |
Large accelerated Filer
o
|
Accelerated Filer
o
|
Non-accelerated Filer
o
|
Smaller Reporting Company
x
|
Page
|
|
PART I
|
|
Item 1. Financial Statements
|
F1-4
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
3
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
6
|
Item 4. Controls and Procedures
|
6
|
PART II
|
|
Item 1. Legal Proceedings
|
7
|
Item 1A. Risk Factors
|
7
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
7
|
Item 3. Defaults Upon Senior Securities
|
7
|
Item 4. Removed and Reserved
|
7
|
Item 5. Other Information
|
7
|
Item 6. Exhibits
|
7
|
ITEM 1.
|
FINANCIAL STATEMENTS.
|
Medical Care Technologies Inc.
|
(A Development Stage Company)
|
June 30, 2010
|
Index
|
|
Consolidated Balance Sheets (unaudited)
|
F-1
|
Consolidated Statements of Expenses (unaudited)
|
F-2
|
Consolidated Statements of Cash Flows (unaudited)
|
F-3
|
Notes to the Consolidated Financial Statements (unaudited)
|
F-4
|
Medical Care Technologies Inc.
|
(A Development Stage Company)
|
Consolidated Balance Sheets
|
(unaudited)
|
June 30,
|
December 31,
|
|||||||
2010
|
2009
|
|||||||
(Restated)
|
||||||||
ASSETS
|
||||||||
Current Assets
|
||||||||
Cash and cash equivalents
|
$ | 1,185 | $ | 475 | ||||
Prepaid expenses
|
45,500 | – | ||||||
Total Current Assets
|
46,685 | 475 | ||||||
Property and equipment, net of accumulated depreciation of $20,000
|
30,000 | – | ||||||
Intangible assets, net of accumulated amortization of $210,564
|
210,564 | – | ||||||
Total Assets
|
$ | 287,249 | $ | 475 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT )
|
||||||||
Current Liabilities
|
||||||||
Accounts payable
|
$ | 56,510 | $ | 31,202 | ||||
Due to related parties
|
35,005 | 25,439 | ||||||
Accrued liabilities
|
4,923 | – | ||||||
Loans payable
|
80,717 | 14,000 | ||||||
Total Current Liabilities
|
177,155 | 70,641 | ||||||
Loans payable
|
– | 56,740 | ||||||
Total Liabilities
|
177,155 | 127,381 | ||||||
Stockholders’ Equity (Deficit)
|
||||||||
Preferred Stock, 100,000,000 shares authorized, $0.00001 par value,
No shares issued and outstanding as of June 30, 2010 and December 31, 2009
|
– | – | ||||||
Common Stock, 150,000,000 shares authorized, $0.00001 par value,
105,400,000 and 98,900,000 shares issued and outstanding as of
June 30, 2010 and December 31, 2009, respectively
|
1,054 | 989 | ||||||
Additional Paid-in Capital
|
881,574 | 50,511 | ||||||
Deficit Accumulated During the Development Stage
|
(772,534 | ) | (178,406 | ) | ||||
Total Stockholders’ Equity (Deficit)
|
110,094 | (126,906 | ) | |||||
Total Liabilities and Stockholders’ Equity (Deficit)
|
$ | 287,249 | $ | 475 |
Medical Care Technologies Inc.
|
(A Development Stage Company)
|
Consolidated Statements of Expenses
|
(unaudited)
|
Period from
|
||||||||||||||||||||
February 27, 2007
|
||||||||||||||||||||
For the three months ended
|
For the six months ended
|
(Inception)
|
||||||||||||||||||
June 30,
|
June 30,
|
To June 30,
|
||||||||||||||||||
2010
|
2009
|
2010
|
2009
|
2010
|
||||||||||||||||
(Restated)
|
(Restated)
|
(Restated)
|
||||||||||||||||||
Expenses
|
||||||||||||||||||||
General and administrative
|
$ | 298,077 | $ | 16,187 | $ | 333,689 | $ | 31,002 | $ | 408,330 | ||||||||||
Depreciation and amortization expense
|
115,282 | – | 230,564 | – | 230,564 | |||||||||||||||
Management fees
|
15,000 | 9,000 | 30,000 | 9,000 | 45,692 | |||||||||||||||
Total Expenses
|
(428,359 | ) | (25,187 | ) | (594,253 | ) | (40,002 | ) | (684,586 | ) | ||||||||||
Foreign currency exchange gain (loss)
|
362 | – | 125 | 72 | (638 | ) | ||||||||||||||
Loss Before Discontinued Operations
|
(427,997 | ) | (25,187 | ) | (594,128 | ) | (39,930 | ) | (685,224 | ) | ||||||||||
Loss from Discontinued Operations:
|
||||||||||||||||||||
Discontinued operations
|
– | – | – | – | (87,310 | ) | ||||||||||||||
Net Loss
|
$ | (427,997 | ) | $ | (25,187 | ) | $ | (594,128 | ) | $ | (39,930 | ) | $ | ( 772,534 | ) | |||||
Net Loss Per Common Share – Basic and Diluted:
|
||||||||||||||||||||
Discontinued Operations
|
N/A | N/A | N/A | N/A | ||||||||||||||||
Continued Operations
|
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.00 | ) | ||||||||
Net Loss
|
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.00 | ) | ||||||||
Weighted Average Common Shares Outstanding – Basic and Diluted
|
102,620,000 | 41,400,000 | 100,930,000 | 58,237,000 |
Medical Care Technologies Inc.
|
(A Development Stage Company)
|
Consolidated Statements of Cash Flows
|
(unaudited)
|
Period from
|
||||||||||||
February 27, 2007
|
||||||||||||
Six months ended
|
(Date of Inception)
|
|||||||||||
June 30,
|
To June 30,
|
|||||||||||
2010
|
2009
|
2010
|
||||||||||
(Restated)
|
(Restated)
|
|||||||||||
Operating Activities
|
||||||||||||
Net loss for the period
|
$ | (594,128 | ) | $ | (39,930 | ) | $ | (772,534 | ) | |||
Adjustment to reconcile net loss to cash used in operating activities:
|
||||||||||||
Donated services and expenses
|
– | – | 10,500 | |||||||||
Depreciation and amortization
|
230,564 | – | 230,564 | |||||||||
Stock-based compensation
|
260,000 | – | 260,000 | |||||||||
Changes in operating assets and liabilities:
|
||||||||||||
Prepaid expenses
|
(45,500 | ) | (2,000 | ) | (45,500 | ) | ||||||
Accounts payable
|
25,308 | 28,912 | 56,510 | |||||||||
Accrued liabilities
|
4,923 | 1,420 | 4,923 | |||||||||
Net Cash Used in Operating Activities
|
(118,833 | ) | (11,598 | ) | (255,537 | ) | ||||||
Financing Activities
|
||||||||||||
Issuance of common stock for cash
|
100,000 | – | 141,000 | |||||||||
Proceeds from Loans Payable
|
9,977 | – | 80,717 | |||||||||
Due to related party
|
9,566 | 1,994 | 35,005 | |||||||||
Net Cash Provided by Financing Activities
|
119,543 | 1,994 | 256,722 | |||||||||
Increase (Decrease) in Cash and Cash Equivalent
|
710 | (9,604 | ) | 1,185 | ||||||||
Cash – Beginning of Period
|
475 | 9,791 | – | |||||||||
Cash – End of Period
|
$ | 1,185 | $ | 187 | $ | 1,185 | ||||||
Supplemental Disclosures
|
||||||||||||
Interest paid
|
– | – | – | |||||||||
Income taxes paid
|
– | – | – | |||||||||
Non-Cash Disclosures
|
||||||||||||
Reclass of related party debt to accounts payable
|
$ | 23,445 | $ | – | $ | 46,255 | ||||||
Repurchase of common stock
|
$ | – | $ | 15,000 | $ | 15,000 | ||||||
Shares issued for acquisition of assets
|
$ | 471,128 | $ | – | $ | 471,128 | ||||||
Reclassification from long term to short term debt
|
$ | 56,740 | $ | – | $ | 56,740 |
Medical Care Technologies Inc.
|
(A Development Stage Company)
|
Notes to the Consolidated Financial Statements
|
(unaudited)
|
1.)
|
Development Stage Company and Going Concern
|
2.
|
Asset Acquisition Agreement
|
On January 9, 2010, the Company entered into an Asset Acquisition Agreement to acquire various computers, software, and technologies (the “assets”) held by Great Union Corporation (“Great Union”), a Hong Kong corporation. In consideration, the Company agreed to issue 57,300,000 shares of its common stock, which represents a controlling interest in Medical Care Technologies, Inc. As a result of this transaction, there was a change of control.
|
|
Based on the change in ownership, the assets were recorded based on historical basis and totaled $471,128. Pursuant to the agreement, on February 1, 2010, the Company cancelled 57,300,000 shares of common stock from the former President of the Company and issued these shares to Great Union.
|
Medical Care Technologies Inc.
|
(A Development Stage Company)
|
Notes to the Consolidated Financial Statements
|
(unaudited)
|
2.
|
Asset Acquisition Agreement (continued)
|
Computer hardware
|
1 year
|
Equipment
|
2 year
|
Computer software and database
|
1 year
|
3.
|
Related Party Transactions
|
|
During the six months ended June 30, 2010, the Company recognized $30,000 of management fees. At June 30, 2010, the Company is indebted to the President of the Company for $33,011, representing $30,000 of management fees owed and $3,011 of expenditures paid on behalf of the Company this amount is unsecured, bears no interest and is due on demand. The Company is also indebted to a former director for $1,994 representing expenditures paid on behalf of the Company.
|
||
4.
|
Loans payable
|
|
a)
|
On August 8, 2009, the Company received $5,636 (Cdn$6,000) and entered into a promissory note agreement. Under the terms of the note, the principal of the loan is unsecured and bears no interest if repaid by April 1, 2010. The Company failed to make the principal repayment on April 1, 2010. The note currently bears interest of 12% per annum and is repayable on April 1, 2011. In the event of default, the principal and all accrued interest shall be due and payable thereon.
|
|
b)
|
On August 9, 2009, the Company borrowed $22,000 and entered into a promissory note agreement. Under the terms of the note, the principal of the loan is unsecured and bears no interest if repaid by April 1, 2010. The Company failed to make the principal repayment on April 1, 2010. The note currently bears interest of 12% per annum and is repayable on April 1, 2011. In the event of default, the principal and all accrued interest shall be due and payable thereon.
|
|
c)
|
On August 9, 2009, the Company borrowed $28,740 and entered into a promissory note. Under the terms of the note, the principal of the loan is unsecured and bears no interest if repaid by April 1, 2010. The Company failed to make the principal repayment on April 1, 2010. The note currently bears interest of 12% per annum and is repayable on April 1, 2011. In the event of default, the principal and all accrued interest shall be due and payable thereon.
|
|
d)
|
On November 18, 2009, the Company borrowed $14,000 pursuant to a promissory note. Under the terms of the note, the principal of the loan is unsecured and bears no interest if repaid by April 1, 2010. The Company failed to make the principal repayment on April 1, 2010. The note currently bears interest of 12% per annum and is repayable on April 1, 2011. In the event of default, the principal and all accrued interest shall be due and payable thereon.
|
|
e)
|
On March 30, 2010 the Company borrowed $10,341 pursuant to a promissory note. Under the terms of the note, the principal of the loan is unsecured and bears no interest if repaid by April 1, 2010. The Company failed to make the principal repayment on April 1, 2010. The note currently bears interest of 12% per annum and is repayable on April 1, 2011. In the event of default, the principal and all accrued interest shall be due and payable thereon.
|
|
5.
|
Common and Preferred Stock
|
|
a)
|
The preferred stock may be divided into and issued in series by the Board of Directors. The Board is authorized to fix and determine the designations, rights, qualifications, preferences, limitations and terms, within legal limitations. As of June 30, 2010 and December 31, 2009, there was no preferred stock issued and outstanding.
|
|
b)
|
On February 1, 2010, 57,300,000 shares of common stock were cancelled and returned to treasury by the former President of the Company for $nil consideration.
|
|
c)
|
On February 1, 2010, 57,300,000 shares of common stock with a fair value of $471,128 were issued pursuant to the Asset Acquisition Agreement with Great Union Corporation described in Note 2.
|
d)
|
On January 15, 2010, the Company accepted subscriptions for 500,000 units at $0.20 per unit for cash proceeds of $100,000. Each unit consists of one share of common stock of the Company and one common share purchase warrant exercisable at $0.15 per share for a period of 36 months. The Company issued the shares on February 1, 2010.
|
|
e)
|
On May 8, 2010, the Company issued 3,500,000 shares of common stock with a fair value of $157,500 pursuant to the two consulting agreements. Refer to Notes 6(a) and (b).
|
|
f)
|
On May 18, 2010, the Company issued 2,500,000 shares of common stock with a fair value of $102,500 pursuant to a consulting agreement dated May 18, 2010. The term of the agreement is six months. Refer to Note 6(c).
|
|
6.
|
Commitments
|
|
a)
|
On May 8, 2010, the Company entered into consulting agreement for corporate and management consulting services. Pursuant to the agreement, the Company agreed to issue 1,100,000 shares of common stock registered under an S-8 registration statement. The Company will issue 500,000 shares (the “Retainer Shares”) upon the execution of the agreement, and the remaining 600,000 shares upon the written approval by the Company of services rendered by the consultant, which services shall be described in writing and presented by consultant to the Company before the expiration of the agreement. The term of the agreement is 60 days commencing the date the Retainer Shares are delivered to the consultant. On May 8, 2010, the Company issued 500,000 shares at a fair value of $22,500.
|
|
b)
|
On May 8, 2010, the Company entered into consulting agreement for website consulting services. Pursuant to the agreement, the Company agreed to issue 3,800,000 shares of common stock registered under an S-8 registration statement. The Company will issue 3,000,000 shares (the “Retainer Shares”) upon the execution of the agreement, and the remaining 800,000 shares upon the delivery by the consultant of a new website for the Company. The term of the agreement is 60 days commencing the date the Retainer Shares are delivered to the consultant. On May 8, 2010, the Company issued 3,000,000 shares at a fair value of $135,000.
|
|
c)
|
On May 18, 2010, the Company entered into a consulting agreement for information technology consulting services. Pursuant to the agreement, the Company agreed to issue 2,500,000 restricted shares of common stock of the Company. The term of the agreement is six months. On May 18, 2010, the Company issued 2,500,000 shares at a fair value of $102,500 to the consultant.
|
|
d)
|
On May 18, 2010, the Company entered into a consulting and software development agreement pursuant to which the contractor agreed to build a secure software information platform for the Company in consideration for 1,395,000 shares of common stock, registered under an S-8 registration statement. The 1,395,000 shares are issuable as follows: 775,000 shares upon the completion of the design and development of the software (“Phase I”) and 620,000 shares upon the implementation of the software (“Phase II”). As at June 30, 2010, the contract service was not completed. On August 16, 2010, Phase I was completed and the Company issued 775,000 shares of common stock at a fair value of $23,250.
|
|
7.
|
Restatement
|
|
The Company identified several errors relating to the accounting of share-based compensation to non-employees. During the six months ended June 30, 2010, the Company entered various consulting and software development agreements, which awarded shares to non-employees, but no compensation was recorded. The effect of the restatement is to increase net loss by $260,000 for the three months and six months ended June 30, 2010. Net loss per share for the three months ended June 30, 2010 was unchanged. Net loss per share for the six months ended June 30, 2010 increased by $0.01.
|
||
The following tables reflect the adjustment and restated amounts:
|
June 30, 2010
|
||||||||||||
As Reported
|
Adjustment
|
As Restated
|
||||||||||
Consolidated Balance Sheet
|
||||||||||||
Stockholders’ Equity (Deficit)
|
||||||||||||
Common Stock, 150,000,000 shares authorized, $0.00001 par value,
105,400,000 and 98,900,000 shares issued and outstanding as of
June 30, 2010 and December 31, 2009, respectively
|
$ | 994 | $ | 60 | $ | 1,054 | ||||||
Additional Paid-in Capital
|
621,634 | 259,940 | 881,574 | |||||||||
Deficit Accumulated During the Development Stage
|
(512,534 | ) | (260,000 | ) | (772,534 | ) | ||||||
Total Stockholders’ Deficit
|
110,094 | – | 110,094 | |||||||||
Total Liabilities and Stockholders’ Deficit
|
$ | 287,249 | $ | – | $ | 287,249 |
For the Three Months Ended June 30, 2010
|
||||||||||||
As Reported
|
Adjustment
|
As Restated
|
||||||||||
Consolidated Statement of Operations
|
||||||||||||
Expenses
|
||||||||||||
General and Administrative
|
$ | 38,077 | $ | 260,000 | $ | 298,077 | ||||||
Total Expenses
|
(168,359 | ) | (260,000 | ) | (428,359 | ) | ||||||
Loss before Discontinued Operations
|
(167,997 | ) | (260,000 | ) | (427,997 | ) | ||||||
Net Loss
|
$ | (167,997 | ) | $ | (260,000 | ) | $ | (427,997 | ) | |||
Net Loss Per Common Share – Basic and Diluted:
|
||||||||||||
Discontinued Operations
|
N/A | – | N/A | |||||||||
Continued Operations
|
(0.00 | ) | – | (0.00 | ) | |||||||
Net Loss
|
(0.00 | ) | – | (0.00 | ) |
For the Six Months Ended June 30, 2010
|
||||||||||||
As Reported
|
Adjustment
|
As Restated
|
||||||||||
Consolidated Statement of Operations
|
||||||||||||
Expenses
|
||||||||||||
General and Administrative
|
$ | 73,689 | $ | 260,000 | $ | 333,689 | ||||||
Total Expenses
|
(334,253 | ) | (260,000 | ) | (594,253 | ) | ||||||
Loss before Discontinued Operations
|
(334,128 | ) | (260,000 | ) | (594,128 | ) | ||||||
Net Loss
|
$ | (334,128 | ) | $ | (260,000 | ) | $ | (594,128 | ) | |||
Net Loss Per Common Share – Basic and Diluted:
|
||||||||||||
Discontinued Operations
|
N/A | – | N/A | |||||||||
Continued Operations
|
(0.00 | ) | (0.01 | ) | (0.01 | ) | ||||||
Net Loss
|
(0.00 | ) | (0.01 | ) | (0.01 | ) |
Period from February 27, 2007 (Date of Inception)
to June 30, 2010
|
||||||||||||
As Reported
|
Adjustment
|
As Restated
|
||||||||||
Consolidated Statement of Operations
|
||||||||||||
Expenses
|
||||||||||||
General and Administrative
|
$ | 148,330 | $ | 260,000 | $ | 408,330 | ||||||
Total Expenses
|
(424,586 | ) | (260,000 | ) | (684,586 | ) | ||||||
Loss before Discontinued Operations
|
(425,224 | ) | (260,000 | ) | (685,224 | ) | ||||||
Net Loss
|
$ | (512,534 | ) | $ | (260,000 | ) | $ | (772,534 | ) |
For the Six Months Ended June 30, 2010
|
||||||||||||
As Reported
|
Adjustment
|
As Restated
|
||||||||||
Consolidated Statement of Cash Flows
|
||||||||||||
Net loss for the period
|
$ | (334,128 | ) | $ | (260,000 | ) | $ | (594,128 | ) | |||
Stock-based compensation
|
– | 260,000 | 260,000 |
Period from February 27, 2007 (Date of Inception) to June 30, 2010
|
||||||||||||
As Reported
|
Adjustment
|
As Restated
|
||||||||||
Consolidated Statement of Cash Flows
|
||||||||||||
Net loss for the period
|
$ | (512,534 | ) | $ | (260,000 | ) | $ | (772,534 | ) | |||
Stock-based compensation
|
– | 260,000 | 260,000 | |||||||||
Net Cash Used in Operating Activities
|
$ | (118,833 | ) | – | $ | (118,833 | ) |
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
|
ITEM 3.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
|
ITEM 4.
|
CONTROLS AND PROCEDURES.
|
ITEM 1.
|
LEGAL PROCEEDINGS.
|
ITEM 1A.
|
RISK FACTORS.
|
ITEM 2.
|
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
|
ITEM 3.
|
DEFAULTS UPON SENIOR SECURITIES.
|
ITEM 4.
|
[REMOVED AND RESERVED].
|
ITEM 5.
|
OTHER EVENTS.
|
ITEM 6.
|
EXHIBITS.
|
Exhibit
|
|
No.
|
Document Description
|
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to section 906 of the Sarbanes-Oxley
Act of 2002.
|
MEDICAL CARE TECHNOLOGIES INC.
|
||
Dated: June 1, 2011
|
BY:
|
/s/ Ning C. Wu
|
Ning C. Wu,
|
||
President, Principal Executive Officer,
|
||
Principal Financial Officer, Principal
|
||
Accounting Officer and a member of the
|
||
Board of Directors.
|
Exhibit
|
|
No.
|
Document Description
|
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to section 906 of the Sarbanes-Oxley
Act of 2002.
|
1 Year Medical Care Technologies (PK) Chart |
1 Month Medical Care Technologies (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions